92.QV4HtYWCqVYnNdkRSrO0AOj3SUnYvDu_Cj-pm8ZBnh8.FBl1w-7k_jFlAL9ZctzXTbGgfCaS_VrPfgvc6v4k11Agc37F__LRGWhisg
12/11 Asymchem Laboratories Co., Ltd. announces an Equity Buyback for CNY 700 million worth of its shares. CI
12/11 Asymchem Laboratories Co., Ltd. authorizes a Buyback Plan. CI
23/10 Asymchem Laboratories Tianjin Posts Higher Q3 Adjusted Attributable Profit; Revenue Up MT
22/10 Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026 CI
22/10 Asymchem Laboratories Posts Higher Q3 Attributable Profit; Revenue Up MT
25/08 Asymchem Laboratories' H1 Profit Declines 16% MT
24/08 Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
31/07 Asymchem Laboratories to Subscribe for Subsidiary's New Shares for 1.05 Billion Yuan; Shares Up 6% MT
30/07 Shanghai Asymchem Biotechnology Development Co., Ltd. announced that it expects to receive CNY 1.239699995 billion in funding from Asymchem Laboratories Co., Ltd., Suzhou Gao Ling Qirui Healthcare Investment, L.P. and another investor CI
27/07 AsymBio, Subsidiary of Asymchem Group Kicks Off Construction of Fengxian R&D Building CI
10/07 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to 175.98 Yuan From 132.37 Yuan, Keeps at Buy MT
10/07 Nomura Adjusts Asymchem Laboratories (Tianjin)'s Price Target to HK$131.48 From HK$115.43, Keeps at Buy MT
12/06 Asymchem Laboratories Co., Ltd. Approves Final Profit Distribution Plan to Be Implemented (A Shares) for 2025, Payable on June 26, 2026 CI
27/05 AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates GL
27/05 AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates AQ
27/05 Asymbio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates CI
20/05 Citigroup's long position in H shares of Asymchem Laboratories (Tianjin) decreases to 4.99% on May 14 from 5.66%, HKEX filing says RE
15/05 Asymchem Laboratories Co., Ltd. Recommends Final Dividend for the Year Ended 31 December 2025, Payable on 24 July 2026 CI
13/05 Citigroup's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 5.36% on May 7, HKEX says RE
04/05 JPMorgan Chase's long position in H-shares of Asymchem Laboratories (Tianjin) decreases to 7.64% on Apr 28 from 8.18%, HKEX filing shows RE
28/04 Asymchem Laboratories' Profit Falls 6.8% in Q1; Shares Rise 8% MT
28/04 Asymchem Laboratories Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
27/04 Asymchem Laboratories (Tianjin) Q1 net profit down 6.8% Y/Y RE
21/04 Asymchem Laboratories Profit Rises 19% in 2025 MT
14/04 Asymchem Unveils Fully Integrated TIDES Commercial Supply Matrix CI

Become a member to access more news

New member
No results match your criteria
  1. Stock Market
  2. Stocks
  3. 002821 Stock
  4. ASLT.Y Stock
  5. News Asymchem Laboratories (Tianjin) Co., Ltd.